New impact factor and many new studies

QR Code

New impact factor and many new studies

Enregistré dans:

Détails bibliographiques
Auteur principal:	Çetin Erol
Format:	article
Langue:	EN
Publié:	KARE Publishing 2021
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/b8ac91f12b75440ab4132a2ce608ca7c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Energy drinks, pulmonary hypertension, and many more
par: Çetin Erol
Publié: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
par: Çetin Erol
Publié: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
par: Çetin Erol
Publié: (2021)

New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension
par: Çetin Erol
Publié: (2021)

Miscellaneous attractive studies
par: Çetin Erol
Publié: (2021)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
par: Çetin Erol
Publié: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
par: Çetin Erol
Publié: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
par: Çetin Erol
Publié: (2021)

ARNI, LBBB, COVID-19 and various other topics
par: Çetin Erol
Publié: (2021)

Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction
par: Lidija Savic, et autres
Publié: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
par: Alberto J Lorenzatti, et autres
Publié: (2020)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
par: Chris Wai Hang Lo, et autres
Publié: (2021)

Time for a new paradigm shift in myocardial infarction
par: Emre K. Aslanger, et autres
Publié: (2021)

A New Era in Zero X-ray Ablation
par: Giuseppe Mascia, et autres
Publié: (2020)

Ivabradine and AF: Coincidence, Correlation or a New Treatment?
par: Mahmoud Abdelnabi, et autres
Publié: (2020)

New opportunities for reducing cardiovascular risk in the Russian Federation
par: O. D. Ostroumova, et autres
Publié: (2020)

The New Heart Failure Association Definition of Advanced Heart Failure
par: Marco Metra, et autres
Publié: (2019)

Journal Impact Factor: Widely Used, Misused and Abused
par: Demosthenes G Katritsis
Publié: (2019)

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
par: Giuseppe Galati, et autres
Publié: (2021)

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients
par: Alessandra Cuomo, et autres
Publié: (2019)

Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias
par: Chen Wei, et autres
Publié: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
par: BMY Cheung, et autres
Publié: (2020)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
par: Yutao Guo, et autres
Publié: (2020)

Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot
par: Mette E Estensen, et autres
Publié: (2021)

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
par: Edoardo Bertero, et autres
Publié: (2019)

Correction: Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot
Publié: (2021)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
par: Jonathan Yap, et autres
Publié: (2021)

New Challenging Scenarios in Transcatheter Aortic Valve Implantation: Valve-in-valve, Bicuspid and Native Aortic Regurgitation
par: Sandra Santos-Martínez, et autres
Publié: (2021)

A new score model to predict the inducibility of supraventricular tachycardia in patients with palpitation without documented electrocardiography
par: Yusuf Türkmen, et autres
Publié: (2021)

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
par: Pier D Lambiase
Publié: (2021)

Decompression of the left heart chambers via atrial flow regulator: A new insight into heart failure treatment
par: Uğur Nadir Karakulak, et autres
Publié: (2021)

Ultrasound-guided Axillary Vein Puncture in Cardiac Lead Implantation: Time to Move to a New Standard Access?
par: Ana Paula Tagliari, et autres
Publié: (2020)

Analysis of 180 genetic variants in a new interactive FX variant database reveals novel insights into FX deficiency
par: Victoria Anne Harris, et autres
Publié: (2021)

Effect of the Extent of Cardiac Damage on Transcatheter Aortic Valve Replacement Outcome: A New Aortic Stenosis Staging System
par: Miho Fukui, et autres
Publié: (2020)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
par: Johan Ärnlöv, et autres
Publié: (2021)

Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
par: İbrahim Halil Özdemir, et autres
Publié: (2021)

Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study
par: Joanne Kathryn Taylor, et autres
Publié: (2021)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
par: An De Sutter, et autres
Publié: (2020)

Correction:Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
Publié: (2021)

The Impact of Ethnicity on Cardiac Adaptation
par: Uchenna Ozo, et autres
Publié: (2020)